Asia Pacific Anti-Viral Therapies Market
The Asia Pacific Anti-Viral Therapies Market size was valued at US$ 8,135.93 Mn in 2019 and is projected to reach US$ 16,118.52 Mn by 2027, growing at a CAGR of 9.0% during 2020 - 2027.
Report Coverage
- Type: Generic Drugs, Branded Drugs
- Mechanism of Action: Nucleotide Polymerase Inhibitors, Reverse Transcriptase Inhibitors, Protease Inhibitors
- Application: HIV, Hepatitis, Virus Influenza, Herpes, Other Applications
US$ 8,135.93 Mn
Market size in 2019
US$ 16,118.52 Mn
Market Size by 2027
9.0%
CAGR, 2020 - 2027
2020-2027
Forecast Period
1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. Asia Pacific Anti-Viral Therapies Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. Asia Pacific Anti-Viral Therapies Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. Asia Pacific Anti-Viral Therapies Market Regional Analysis
6.2 Asia Pacific Anti-Viral Therapies Market Revenue 2017-2027 (US$ Million)
6.3 Asia Pacific Anti-Viral Therapies Market Forecast Analysis
7. Asia Pacific Anti-Viral Therapies Market Analysis – by Type
7.1 Generic Drugs
- 7.1.1 Overview
- 7.1.2 Generic Drugs: Asia Pacific Anti-Viral Therapies Market – Revenue and Forecast, 2017-2027 (US$ Million)
7.2 Branded Drugs
- 7.2.1 Overview
- 7.2.2 Branded Drugs: Asia Pacific Anti-Viral Therapies Market – Revenue and Forecast, 2017-2027 (US$ Million)
8. Asia Pacific Anti-Viral Therapies Market Analysis – by Mechanism of Action
8.1 Nucleotide Polymerase Inhibitors
- 8.1.1 Overview
- 8.1.2 Nucleotide Polymerase Inhibitors: Asia Pacific Anti-Viral Therapies Market – Revenue and Forecast, 2017-2027 (US$ Million)
8.2 Reverse Transcriptase Inhibitors
- 8.2.1 Overview
- 8.2.2 Reverse Transcriptase Inhibitors: Asia Pacific Anti-Viral Therapies Market – Revenue and Forecast, 2017-2027 (US$ Million)
8.3 Protease Inhibitors
- 8.3.1 Overview
- 8.3.2 Protease Inhibitors: Asia Pacific Anti-Viral Therapies Market – Revenue and Forecast, 2017-2027 (US$ Million)
9. Asia Pacific Anti-Viral Therapies Market Analysis – by Application
9.1 HIV
- 9.1.1 Overview
- 9.1.2 HIV: Asia Pacific Anti-Viral Therapies Market – Revenue and Forecast, 2017-2027 (US$ Million)
9.2 Hepatitis
- 9.2.1 Overview
- 9.2.2 Hepatitis: Asia Pacific Anti-Viral Therapies Market – Revenue and Forecast, 2017-2027 (US$ Million)
9.3 Virus Influenza
- 9.3.1 Overview
- 9.3.2 Virus Influenza: Asia Pacific Anti-Viral Therapies Market – Revenue and Forecast, 2017-2027 (US$ Million)
9.4 Herpes
- 9.4.1 Overview
- 9.4.2 Herpes: Asia Pacific Anti-Viral Therapies Market – Revenue and Forecast, 2017-2027 (US$ Million)
9.5 Other Applications
- 9.5.1 Overview
- 9.5.2 Other Applications: Asia Pacific Anti-Viral Therapies Market – Revenue and Forecast, 2017-2027 (US$ Million)
10. Asia Pacific Anti-Viral Therapies Market – Asia-Pacific Analysis
10.1 Overview
10.2 Asia-Pacific- 10.2.1 Asia Pacific Anti-Viral Therapies Market Breakdown, by Key Country, 2020 and 2027 (%)
- 10.2.1.1 Asia Pacific Anti-Viral Therapies Market – Revenue and Forecast Analysis – by Country
- 10.2.1.1 China: Asia Pacific Anti-Viral Therapies Market – Revenue and Forecast to 2027 (US$ Million)
- 10.2.1.1.1 China: Asia Pacific Anti-Viral Therapies Market Breakdown, by Type
- 10.2.1.1.2 China: Asia Pacific Anti-Viral Therapies Market Breakdown, by Mechanism of Action
- 10.2.1.1.3 China: Asia Pacific Anti-Viral Therapies Market Breakdown, by Application
- 10.2.1.2 India: Asia Pacific Anti-Viral Therapies Market – Revenue and Forecast to 2027 (US$ Million)
- 10.2.1.2.1 India: Asia Pacific Anti-Viral Therapies Market Breakdown, by Type
- 10.2.1.2.2 India: Asia Pacific Anti-Viral Therapies Market Breakdown, by Mechanism of Action
- 10.2.1.2.3 India: Asia Pacific Anti-Viral Therapies Market Breakdown, by Application
- 10.2.1.3 Japan: Asia Pacific Anti-Viral Therapies Market – Revenue and Forecast to 2027 (US$ Million)
- 10.2.1.3.1 Japan: Asia Pacific Anti-Viral Therapies Market Breakdown, by Type
- 10.2.1.3.2 Japan: Asia Pacific Anti-Viral Therapies Market Breakdown, by Mechanism of Action
- 10.2.1.3.3 Japan: Asia Pacific Anti-Viral Therapies Market Breakdown, by Application
- 10.2.1.4 Australia: Asia Pacific Anti-Viral Therapies Market – Revenue and Forecast to 2027 (US$ Million)
- 10.2.1.4.1 Australia: Asia Pacific Anti-Viral Therapies Market Breakdown, by Type
- 10.2.1.4.2 Australia: Asia Pacific Anti-Viral Therapies Market Breakdown, by Mechanism of Action
- 10.2.1.4.3 Australia: Asia Pacific Anti-Viral Therapies Market Breakdown, by Application
- 10.2.1.5 Rest of Asia-Pacific : Asia Pacific Anti-Viral Therapies Market – Revenue and Forecast to 2027 (US$ Million)
- 10.2.1.5.1 Rest of Asia-Pacific : Asia Pacific Anti-Viral Therapies Market Breakdown, by Type
- 10.2.1.5.2 Rest of Asia-Pacific : Asia Pacific Anti-Viral Therapies Market Breakdown, by Mechanism of Action
- 10.2.1.5.3 Rest of Asia-Pacific : Asia Pacific Anti-Viral Therapies Market Breakdown, by Application
11. Competitive Landscape
11.1 Heat Map Analysis
11.2 Company Positioning and Concentration
12. Industry Landscape
12.1 Overview
12.2 Market Initiative
12.3 Partnerships and Collaborations
12.4 Other Developments
13. Company Profiles
13.1 Aurobindo Pharma Ltd
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 AbbVie Inc.
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 GlaxoSmithKline plc
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 AstraZeneca
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 F. HOFFMANN-LA ROCHE LTD
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
14. Appendix
14.1 About Business Market Insights
14.2 List of Abbreviations
Access the Full A Market Report
Get segment-level forecasts, regional estimates, competitive benchmarking, company profiles and downloadable Excel datasets.
